HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement in antenatal diagnosis of critical congenital heart disease implications for postnatal care and screening.

AbstractOBJECTIVE:
This observational study was performed to examine the current timing and mode of diagnosis of critical congenital heart disease (CCHD), since early detection of cardiac lesions can significantly improve morbidity and mortality.
METHOD:
Ninety cases of CCHD in infants born in Middle Tennessee in 2009 were identified by weekly review of admissions to a single cardiac referral center. CCHD is defined as lesions requiring admission or re-admission for surgical or medical intervention within 1 month of life.
RESULTS:
Overall, the observed antenatal detection rate of 49% is significantly greater than published values of 25%. Hypoplastic left heart syndrome was detected in 11/11, but only 5/16 coarctations were detected.
CONCLUSION:
Compared to earlier reports, our study showed a doubling of the antenatal detection rate. Perhaps efforts to improve early diagnosis of CCHD could focus on antenatal ultrasound screening techniques for lesions that are missed most often as well as on postnatal screening.
AuthorsStephanie W Israel, Lindsay R Roofe, Benjamin R Saville, William F Walsh
JournalFetal diagnosis and therapy (Fetal Diagn Ther) Vol. 30 Issue 3 Pg. 180-3 ( 2011) ISSN: 1421-9964 [Electronic] Switzerland
PMID21525728 (Publication Type: Journal Article)
CopyrightCopyright © 2011 S. Karger AG, Basel.
Topics
  • Early Diagnosis
  • Female
  • Fetal Diseases (diagnosis, diagnostic imaging)
  • Heart Defects, Congenital (diagnosis, diagnostic imaging)
  • Humans
  • Infant, Newborn
  • Neonatal Screening
  • Postnatal Care
  • Pregnancy
  • Survival Rate
  • Time Factors
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: